Atlas Trials

CHAPLE Disease

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch CHAPLE Disease

RecordFirmDate
A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease (NCT07142343)Regeneron Pharmaceuticals2026-03-19

Track CHAPLE Disease automatically

Every clearance here is in the API, with alerts when new ones post.